Literature DB >> 22414088

In vitro - in vivo correlation of gene expression alterations induced by liver carcinogens.

T Heise1, M Schug, D Storm, H Ellinger-Ziegelbauer, H J Ahr, B Hellwig, J Rahnenfuhrer, A Ghallab, G Guenther, J Sisnaiske, R Reif, P Godoy, H Mielke, U Gundert-Remy, A Lampen, A Oberemm, J G Hengstler.   

Abstract

Although cultivated hepatocytes are widely used in the studies of drug metabolism, their application in toxicogenomics is considered as problematic, because previous studies have reported only little overlap between chemically induced gene expression alterations in liver in vivo and in cultivated hepatocytes. Here, we identified 22 genes that were altered in livers of rats after oral administration of the liver carcinogens aflatoxin B1 (AB1), 2-nitrofluorene (2-NF), methapyrilene (MP) or piperonyl-butoxide (PBO). The functions of the 22 genes have been classified into two groups. Genes related to stress response, DNA repair or metabolism and genes associated with cell proliferation, respectively. Next, rat hepatocyte sandwich cultures were exposed to AB1, 2-NF, MP or PBO for 24h and expression of the above mentioned genes was determined by RT-qPCR. Significant correlations between the degree of gene expression alterations in vivo and in vitro were obtained for the stress, DNA repair and metabolism associated genes at concentrations covering a range from cytotoxic concentrations to non-toxic/in vivo relevant concentrations. In contrast to the stress associated genes, no significant in vivo/in vitro correlation was obtained for the genes associated with cell proliferation. To understand the reason of this discrepancy, we compared replacement proliferation in vivo and in vitro. While hepatocytes in vivo, killed after administration of hepatotoxic compounds, are rapidly replaced by proliferating surviving cells, in vitro no replacement proliferation as evidenced by BrdU incorporation was observed after washing out hepatotoxic concentrations of MP. In conclusion, there is a good correlation between gene expression alterations induced by liver carcinogens in vivo and in cultivated hepatocytes. However, it should be considered that cultivated primary hepatocytes do not show replacement proliferation explaining the in vivo/in vitro discrepancy concerning proliferation associated genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22414088     DOI: 10.2174/092986712799945049

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  8 in total

1.  New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformatics.

Authors:  Brandi N Snyder-Talkington; Yong Qian; Vincent Castranova; Nancy L Guo
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2012       Impact factor: 6.393

Review 2.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

3.  Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.

Authors:  Christoph Thiel; Henrik Cordes; Isabel Conde; José Vicente Castell; Lars Mathias Blank; Lars Kuepfer
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

4.  Enigmatic mechanism of the N-vinylpyrrolidone hepatocarcinogenicity in the rat.

Authors:  Franz Oesch; Daniela Fruth; Jan G Hengstler; Eric Fabian; Franz Ingo Berger; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2021-09-30       Impact factor: 5.153

5.  Highlight report: Software for tissue analysis and reconstruction.

Authors:  Mohie A M Haridy; Yasser S El-Sayed
Journal:  EXCLI J       Date:  2015-09-23       Impact factor: 4.068

6.  Advances in 2D and 3D in vitro systems for hepatotoxicity testing.

Authors:  Seddik Hammad
Journal:  EXCLI J       Date:  2013-11-28       Impact factor: 4.068

7.  Highlight report: Blueprint for stem cell differentiation into liver cells.

Authors:  Ahmed Ghallab
Journal:  EXCLI J       Date:  2015-09-02       Impact factor: 4.068

8.  Transcriptomics in developmental toxicity testing.

Authors:  H M Bolt
Journal:  EXCLI J       Date:  2013-12-12       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.